Rangers activate Josh Jung and Nathan Eovaldi from injured list

The Texas Rangers activated third baseman Josh Jung and starting pitcher Nathan Eovaldi from the injured list, MLB.com reported, with Kennedi Landry noting both players had an immediate impact upon their return.

What happened

The Rangers returned two significant pieces to their active roster, with Jung rejoining the infield and Eovaldi slotting back into the pitching rotation. Kennedi Landry reported the moves for MLB.com, describing both players as having instant impact in their returns.

Jung's path back was a gradual one. About a week before this activation, Jung had begun a rehab assignment with Triple-A Round Rock while recovering from a calf strain — a standard procedural step that allows players to shake off rust and test the injury under game conditions before rejoining the big-league club. That assignment has now concluded with his return to the active roster.

Eovaldi's return puts a veteran arm back at the top of the rotation at a moment when the Rangers can least afford to be short-handed. As a pitcher, he was subject to the 15-day injured list minimum, and his return to the rotation gives Texas a known quantity in a stretch run where every start carries weight.

Why it matters

The Rangers are in the middle of a genuine playoff race, and the timing of these activations is not incidental. Texas sits 2.0 games outside the Wild Card cut line, ranked fifth in the Wild Card standings. Getting a starting pitcher and an everyday third baseman back simultaneously is the kind of roster consolidation that a team in this position needs — not a luxury, but a requirement.

Jung's return stabilizes the infield at a position that had been navigating his absence. Third base is not a spot where teams carry obvious depth, and the calf strain that sent him to Round Rock for a rehab stint had left a gap in the lineup. His activation closes it.

Eovaldi's return to the rotation matters for a different reason. Starting pitching depth is the currency of September, and a veteran who can eat innings and keep a game close is worth considerably more in the final weeks than he would be in April. The Rangers' upcoming schedule — three games against the Boston Red Sox at Globe Life Field, followed by a series against the Toronto Blue Jays — arrives at exactly the moment Eovaldi is available to contribute.

It is also worth noting the broader context of the Rangers' roster activity over the past week. Robert Garcia returned from the injured list to bolster the bullpen, and separately, Joc Pederson exited a game after being hit by a pitch on his left hand — though X-rays came back negative on that occasion. The club has been managing its roster carefully through this stretch, and the Jung and Eovaldi activations represent the most significant additions of that recent run.

The numbers

Texas enters this stretch at 74-76 (.493), sitting second in the AL West and 1 game back in the division. The Wild Card picture is tighter: the Rangers are ranked fifth, 2.0 games relative to the cut line. They have won their last two games, a modest streak that at least points in the right direction.

Those numbers frame the stakes plainly. A team at .493 with two weeks remaining in the regular season does not have margin for error. Every game in the upcoming homestand against Boston and Toronto is a direct opportunity to close that 2.0-game gap, and having Jung and Eovaldi available for those games rather than watching from the injured list is a meaningful operational difference.

Where the club stands

The Rangers host the Boston Red Sox on Wednesday, September 16, with MacKenzie Gore taking the mound against Jake Bennett. Thursday's game against Boston lists the Texas starter as TBD, with Sonny Gray going for the Red Sox. The Blue Jays arrive Friday, September 18, for a series at Globe Life Field.

Eovaldi's return to the rotation means the Rangers now have decisions to make about how to sequence their starters through that homestand. The Thursday TBD slot is the obvious place to watch — whether Eovaldi steps into that role or is held for a later start will tell you something about how the club is managing his workload coming off the injured list.

Jung's presence in the lineup gives the Rangers their full infield complement for a homestand against two opponents they need to beat. The September roster expansion — which allows clubs to carry 28 active players — gives Texas some flexibility in how it constructs its bench around the returning players.

What we don't know yet

Kennedi Landry's MLB.com report does not specify what corresponding roster moves were made to clear space for both activations, nor does it detail the nature of Eovaldi's injury or how long he was on the injured list. Jung's calf strain was the reported reason for his IL stint and subsequent rehab assignment, but the full timeline of his absence is not laid out in the available reporting.

It is also not yet clear where Eovaldi slots in the rotation order for the upcoming series, given that Thursday's starter remains listed as TBD. Whether the club intends to manage his innings carefully in his first start back, or whether he returns to a full workload immediately, has not been reported.

What to watch

The Thursday starter designation is the most immediate open question. If Eovaldi takes that slot against Boston, it would be his first start back from the IL against a Red Sox team that will have its own playoff considerations. How the Rangers sequence their rotation through the Blue Jays series that follows will also be worth tracking.

For Jung, the question is simply whether the calf holds up under the demands of everyday play. A rehab assignment at Triple-A Round Rock is designed to answer that question before the player returns, but the first week back in the majors is always the real test. The Rangers need him healthy and in the lineup, not just available in a pinch.

With 2.0 games separating Texas from a Wild Card spot and a two-game winning streak providing a small tailwind, the next ten days at Globe Life Field will go a long way toward determining whether this roster consolidation came in time to matter.